Obesity treatment: the key to managing the type 2 diabetes timebomb?

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Articles by Wilding, J.
	Search for Related Content

Social Bookmarking

	What's this?

John Wilding

Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Longmoor Lane, Liverpool, L9 7AL, UK, j.p.h.wilding{at}liv.ac.uk

References

Medicare payment advisory commission. Healthcare Spending and the medicare program. 2004.

Currie CJ, Kraus D., Morgan CL, Gill L., Stott NCH, Peters JR NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care. Diabet Med 1997;14:686-92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Chan JM, Stampfer MJ, Ribb EB, Willett WC, Colditz GA Obesity, fat distribution and weight gain as risk factors for clinical diabetes in man. Diabetes Care 1994;17:961-9.[Abstract]

Hu FB, Manson JE, Stampfer MJ et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-7.[Abstract/Free Full Text]

Jayapaul MK, Walker M. Mechanisms contributing to the development of type 2 diabetes. Br J Diabetes Vasc Dis 2004;4:227-31.[Abstract/Free Full Text]

Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003;362:1275-81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Tuomilheto J., Lindstrom J., Erickson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle anongst subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.[Abstract/Free Full Text]

Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.[Abstract/Free Full Text]

Buchanan TA, Xiang AH, Peters RK et al. Protection from type 2 diabetes persists in the TRIPOD cohort eight months after stopping troglitazone. Diabetes 2001;50:A81.

Chiasson JL, Josse RG, Gomis R., Hanefeld M., Karasik A., Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial. Lancet 2002;359:2072-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Torgerson JS, Hauptman J., Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care 2004;27:155-61.[Abstract/Free Full Text]

Sjostrom CD, Lissner L., Wedel H., Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: The SOS Intervention Study. Obes Res 1999;7:477-84.[Web of Science][Medline] [Order article via Infotrieve]

Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it - an operation proves to be the most effective therapy for adult-onset diabetes-mellitus. Ann Surg 1995;222:339-52.[Web of Science][Medline] [Order article via Infotrieve]

Tringham JR, Davies MJ Screening for IGT and diabetes. Br J Diabetes Vasc Dis 2004;4:254-8.[Abstract/Free Full Text]

Banerjee M., Cruickshank JK `Prediabetes': is the term useful? Br J Diabetes Vasc Dis 2004;4:221-5.

Palmer AJ, Roze S., Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the Diabetes Prevention Program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther 2004;26:304-21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Mohanty P., Aljada A., Ghanim H. et al. Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab 2004;89:2728-35.[Abstract/Free Full Text]

Bennett SMA, Agrawal A., Elashat H. et al. Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. Diabet Med 2004;21:415-22.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Sjostrom L., Larsson B., Backman L., Bengtsson C., Bouchard C., Dahlgren S.e.a. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 1992;16:465-79.[Web of Science][Medline] [Order article via Infotrieve]

Wing RR, Koeske R., Epstein LH, Nowalk MP, Gooding W., Becker D. Long-term effects of modest weight-loss in type-ii diabetic-patients. Arch Intern Med 1987;147:1749-53.[Abstract/Free Full Text]

McNulty SJ, Ur E., Williams G. A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin. Diabetes Care 2003;26:125-31.[Abstract/Free Full Text]

Hollander PA, Elbein SC, Hirsch IB et al. Role of orlistat in the treatment of obese patients with type 2 diabetes - A 1-year randomized doubleblind study. Diabetes Care 1998;21:1288-94.[Abstract]

Manley SE, Stratton IM, Cull CA et al. Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group. Diabet Med 2000;17:518-23.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Pinkney J., Kerrigan D. When should bariatric surgery be used in the treatment of type 2 diabetes? Br J Diabetes Vasc Dis 2004;4:232-7.[Abstract/Free Full Text]

Sjostrom L., Rissanen A., Andersen T. et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998;352:167-72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

James WPT, Astrup A., Finer N. et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet 2000;356: 2119-25.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group. Metabolism 1990;39:905-12.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Dixon JB, O'Brien PE Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25:358-63.[Abstract/Free Full Text]